Tudor Investment Corp’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
TCM
DGM
VPC
CP
ACM
HI
Tudor Investment Corp's ABVX Position: Q1 2026 in Review
Tudor Investment Corp increased its Abivax (ABVX) stake by 256% in Q1 2026, buying an estimated $8.65M and bringing the position to 101,611 shares worth $11.3M. The position accounts for 0.02% of the portfolio, ranked #674.
Tudor Investment Corp first reported a position in ABVX in Q4 2023 and has held it in 4 quarters since. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.
- Tudor Investment Corp held 101,611 shares of Abivax worth $11.3M as of Q1 2026.
- Tudor Investment Corp bought 73,075 Abivax shares in Q1 2026, an estimated $8.65M.
- Abivax made up 0.02% of Tudor Investment Corp's portfolio in Q1 2026, its #674 holding.
- Tudor Investment Corp first reported a position in Abivax in Q4 2023 and has held it in 4 quarters since.
- 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.
Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.